Pediatric long‐term noninvasive respiratory support in children with central nervous system disorders
Marion Carrara, Guillaume Aubertin, Sonia Khirani, Bruno Massenavette, Priscille Bierme, Lucie Griffon, Iulia Ioan, Cyril Schweitzer, Alexandra Binoche, Marie‐Emilie Lampin, Clémence Mordacq, Robert Rubinsztajn, Stéphane Debeilleix, François Galode, Stéphanie Bui, Eglantine Hullo, Arnaud Becourt, Marc Lubrano, Johan Moreau, Marie‐Catherine Renoux, Stefan Matecki, Nathalie Stremler, Melisande Baravalle‐Einaudi, Julie Mazenq, Elodie Sigur, Géraldine Labouret, Anne‐Laure Genevois, Rachel Heyman, Michael Pomedio, Alexandra Masson, Pauline Hangard, Céline Menetrey, Laurence Le Clainche, Plamen Bokov, Benjamin Dudoignon, Emmanuelle Fleurence, Jean Bergounioux, Blaise Mbieleu, Audrey Breining, Lisa Giovannin‐Chami, Agnes Fina, Morgane Ollivier, Elsa Gachelin, Caroline Perisson, Anne Pervillé, Audrey Barzic, Pierrick Cros, Mickaël Jokic, Guillaume Labbé, Véronique Diaz, Laurianne Coutier, Brigitte Fauroux, Jessica Taytard- Pulmonary and Respiratory Medicine
- Pediatrics, Perinatology and Child Health
Abstract
Rationale
The use of long‐term noninvasive respiratory support is increasing in children along with an extension of indications, in particular in children with central nervous system (CNS) disorders.
Objective
The aim of this study was to describe the characteristics of children with CNS disorders treated with long‐term noninvasive respiratory support in France.
Methods
Data were collected from 27 French pediatric university centers through an anonymous questionnaire filled for every child treated with noninvasive ventilatory support ≥3 months on 1st June 2019.
Main Results
The data of 182 patients (55% boys, median age: 10.2 [5.4;14.8] years old [range: 0.3–25]) were collected: 35 (19%) patients had nontumoral spinal cord injury, 22 (12%) CNS tumors, 63 (35%) multiple disabilities, 26 (14%) central alveolar hypoventilation and 36 (20%) other CNS disorders. Seventy five percent of the patients were treated with noninvasive ventilation (NIV) and 25% with continuous positive airway pressure (CPAP). The main investigations performed before CPAP/NIV initiation were nocturnal gas exchange recordings, alone or coupled with poly(somno)graphy (in 29% and 34% of the patients, respectively). CPAP/NIV was started in an acute setting in 10% of the patients. Median adherence was 8 [6;10] hours/night, with 12% of patients using treatment <4 h/day. Nasal mask was the most common interface (70%). Airway clearance techniques were used by 31% of patients.
Conclusion
CPAP/NIV may be a therapeutic option in children with CNS disorders. Future studies should assess treatment efficacy and patient reported outcome measures.